JA
Jazz Pharma
JAZZ·NASDAQDublin IEFounded 20032,400 employees
Mid CappharmaPublicNeurologyOncologyRare Disease
Platform: CNS & Hem
Market Cap
$9B
All Drugs
4
Clinical Trials
7
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (JAZZ)
Loading JAZZ stock data...
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Semasacituzumab | JAZ-8840 | Phase 2 | 2 | AHR | GBMPNH | ||
| Polalucimab | JAZ-8814 | Preclinical | 2 | PLK4 | ThymomaCKD | ||
| JAZ-8729 | JAZ-8729 | Phase 2/3 | 2 | FcRn | MSAS | ||
| Nirafotisoran | JAZ-5262 | Phase 2/3 | 1 | TROP-2 | MDD |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)